Evidence map›Paper›PMID 39558917›Full record

ArticleInternational journal of nanomedicine2024

Comparative Study and Transcriptomic Analysis on the Antifungal Mechanism of Ag Nanoparticles and Nanowires Against

Minna Han, Zhikuan Xia, Yuekun Zou, Ping Hu, Mingwang Zhang, Xin Yang, Ming-Guo Ma, Rongya Yang

Abstract readComparative Study
In one paragraph

Article in International journal of nanomedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Minna Han *Chinese PLA Medical School, Beijing, 100072, People's Republic of China.
Zhikuan Xia *Department of Dermatology, The Seventh Medical Center of PLA General Hospital, Beijing, 100072, People's Republic of China.
Yuekun ZouDepartment of Geriatrics, The Sixth Medical Center of PLA General Hospital, Beijing, 100072, People's Republic of China.
Ping HuDepartment of Dermatology, Southern Medical Branch of PLA General Hospital, Beijing, 100072, People's Republic of China.
Mingwang ZhangDepartment of Dermatology, Southwest Hospital, Army Medical University, Chongqing, People's Republic of China.
Xin YangDepartment of Geriatrics, The Sixth Medical Center of PLA General Hospital, Beijing, 100072, People's Republic of China.
Ming-Guo MaCollege of Materials Science and Technology, Beijing Forestry University, Beijing, 100083, People's Republic of China.
Rongya YangDepartment of Dermatology, The Seventh Medical Center of PLA General Hospital, Beijing, 100072, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Silver nanomaterials have been widely proven to have antifungal effects against Methods: Herein, the antifungal effect of silver nanomaterials against fungus was comparative investigated via silver nanowires and silver nanoparticles with a similar size (30 nm). Results: The optimal antifungal concentration of silver nanowires is 6.24 μg/mL, meanwhile the antifungal concentration of silver nanoparticles is 100 μg/mL. The silver nanowires are significantly superior to the silver nanoparticles. SEM and TEM results indicated that both silver nanoparticles and silver nanowires showed significant morphological changes in the mycelium of the strain, compared with the control. The lower MFC value of silver nanowires indicates good sterilization effect and suitability for eradication treatment, which is slower than that of silver nanoparticles. Moreover, we also investigated the toxicological effects of silver nanoparticles and silver nanowires. Conclusion: We comparative studied and transcriptomic analyzed the antifungal mechanism of Ag nanoparticles and nanowires against

Indexed as

Antifungal AgentsMetal NanoparticlesNanowiresSilverBasidiomycotaGene Expression ProfilingMicrobial Sensitivity TestsParticle SizeTranscriptomeTrichosporonAntifungal AgentsSilverAgantifungal mechanismfungusnanoparticlesnanowirestranscriptomicsTrichosporon asahii

Identifiers

PMID39558917
PMCPMC11571931

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.